This acquisition will add asthma treatment A1O-001 to GSK’s portfolio.
Beyond the Ordinary Beyond the Obvious
Beyond the Ordinary Beyond the Obvious
This acquisition will add asthma treatment A1O-001 to GSK’s portfolio.
